Our CEO and co-founder Matteo Cornaglia will pitch Nagi’s revolutionary technology at the “A glimpse of the Swiss innovation system” session tomorrow 17th November at 2pm local hour (Hall 5).
Our CEO and co-founder Matteo Cornaglia will represent Nagi Bioscience at the prestigious AIT India Program.
Nagi Bioscience has been selected to be part of the Swiss Biotech Pavilion at BIO-Europe 2022, which will be held in-person next week in Leipzig (Germany) from Monday 24th until 26th October.
Whole-organism data. Innovative 3Rs test methods all in one device. Curious to meet this technology? See with your own eyes the SydLab System by Nagi Bioscience at our booth at the 2022 Swiss 3Rs Day in Bern next Tuesday 11th October.
Meet the SydLab System by Nagi Bioscience at the EUSAAT Congress from Monday 26th until Wednesday 28th September at Linz, Austria.
As part of the study, a screening was performed in C. elegans using Nagi Bioscience’s fully automated high-content screening platform in order to determine the efficacy and necessary dosage of the test compounds.
We are proud to announce that Nagi Bioscience has entered the distinguished TOP 100 Swiss Start Up 2022 ranking under the biotech category.
Nagi & MolGen in tandem at the European Worm Meeting 2022 at booth #5
Our CEO and co-founder, Matteo Cornaglia, speaks today about the future of New Approach Methodologies and how Nagi Bioscience is fulfilling this market need in an interview for Verve Ventures.
Meet the Organism-on-Chip that is revolutionizing the biotech sector in Nagi’s booth at Future Labs Live in Basel.